雷替曲塞与替吉奥联合奥沙利铂治疗晚期直肠癌患者的临床观察被引量：5

Clinical Observation of Raltitrexe and Tegafur combined with Oxaliplatin in the Treatment of Patients with Advanced Rectal Cancer

下载PDF

导出

摘要目的观察雷替曲塞联合奥沙利铂与奥沙利铂联合替吉奥治疗晚期直肠癌患者的临床疗效。方法选取自2014年4月至2016年4月于中国医科大学附属盛京医院大连医院肿瘤内科收治的晚期直肠癌患者60例,采用信封法随机分为试验组和对照组,对照组30例,采用雷替曲塞联合奥沙利铂方案化疗,试验组30例,采用奥沙利铂联合替吉奥口服方案,观察两组患者的有效率和中位疾病进展时间。结果试验组优于对照组,有统计学差异(P<0.05)。结论雷替曲塞与奥沙利铂联合治疗晚期直肠癌患者具有一定疗效。 Objective To observe the clinical efficacy of raltitrexed combined with oxaliplatin and oxaliplatin plus S-1 in the treatment of patients with advanced colorectal cancer. Methods From April 2014 to April 2016 in 60 cases of Shengjing Hospital affiliated to China Medical University Dalian hospital treated patients with advanced rectal cancer were randomly divided into experimental group and control group using the envelope method, 30 cases in the control group, using raltitrexed combined with oxaliplatin chemotherapy, 30 cases of experimental group, the oxaliplatin plus S-1 oral solution, observe two group of patients with the progress of the efficiency and the median time to disease. Results The experimental group was better than the control group, there was significant difference（P〈0.05）. Conclusion The treatment of patients with advanced rectal cancer with the combination of pemetrexed and oxaliplatin is effective.

作者杨飞 YANG Fei(Department of Oncology,Dalian Hospital,Shengjing Hospital Affliated to China Medical University,Dalian 116600,China)

机构地区中国医科大学附属盛京医院大连医院肿瘤内科

出处《中国医药指南》 2018年第12期42-43,共2页 Guide of China Medicine

关键词雷替曲塞奥沙利铂替吉奥晚期直肠癌 Raltitrexed Oxaliplatin S-1 Advanced rectal cancer

分类号 R735.37 [医药卫生—肿瘤]

引文网络
相关文献

参考文献4

1王佳蕾,李进,秦叔逵,程颖,张清媛,刘天舒,杨春康,叶正宝,徐农,郑磊贞,胡春宏,张沂平,陶敏,于志坚,庄志祥.雷替曲塞或氟尿嘧啶/亚叶酸钙联合奥沙利铂治疗局部晚期或复发转移性结直肠癌的随机对照多中心Ⅲ期临床试验[J].临床肿瘤学杂志,2012,17(1):6-11. 被引量：121
2付晓艳,张宏文,李成林,崔彦,杨鹤鸣,肖阳.雷替曲塞联合奥沙利铂治疗晚期结肠、直肠癌的临床研究[J].实用临床医药杂志,2012,16(7):88-90. 被引量：13
3董保国,谢桂生,李霖,韦皓棠.雷替曲塞联合奥沙利铂治疗术后复发晚期大肠癌的疗效观察[J].中国医学创新,2014,11(2):15-16. 被引量：19
4朱大高,王辉.雷替曲塞联合奥沙利铂治疗晚期结直肠癌的临床疗效观察[J].中国医学创新,2015,12(7):51-53. 被引量：13

二级参考文献45

1Glimelius B, Hoffman K, Graf W, et al. Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group [J]. Cancer, 1994, 73(3) :556 -562.
2Pazdur R, Vincent M. Raltitrexed (Tomudex) versus 5-fluorouracil and leucovorin (5FU + LV) in patients with advanced colorectal cancer (ACC) : resuhs of a randomized, multicenter, North American trial [ C]. Denver:Proc Am Soc, 1997 :a801.
3Cocconi G, Cunningham D, Van Cutsem E, et al. Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group [ J ]. J Clin Oncol, 1998, 16(9) : 2943 -2952.
4Cunningham D, Zalcberg JR, Rath U, et al. Final results of a randomised trial comparing Tomudex ( raltitrexed ) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. 'Tomudex' Colorectal Cancer Study Group [J]. Ann Oncol, 1996, 7(9) : 961 - 965.
5Maughan T, James R, Kerr D, et al. Excess treatment related deaths and impaired quality of life show raltitrexed is inferior to infusional 5FU regimen in the palliative chemotherapy of advanced colorectal cancer ( CRC ) : final results of MRC CRO6 [J]. Ann Oncol, 2000, 11(Suppl4): a1850.
6Cortinovis D, Bajetta E, Di Bartolomeo M, et al. Raltitrexed plus oxaliplatin in the treatment of metastatic colorectal cancer [J]. Tumori, 2004, 90(2):186- 191.
7Laudani A, Gebbia V, Leonardi V, et al. Activity and toxicity of oxaliplatin plus raltitrexed in 5-fluorouracil-refractory metastatic colorectal adeno-carcinoma [J]. Anticancer Res, 2004, 24 (2C) :1139 - 1142.
8Santini D, Massacesi C, D'Angelillo RM, et al. Raltitrexed plus weekly oxaliplatin as first-line chemotherapy in metastatic colorectal cancer: a multicenter non-randomized phase Ⅱ study [J]. Med Oncol, 2004, 21 ( 1 ) :59 -66.
9Martoni A, Mini E, Pinto C, et al. Oxaliplatin plus rahitrexed in the treatment of patients with advanced colorectal cancer: a phase Ⅱ study [J]. AnticancerRes, 2003, 23(1B):687-691.
10Neri B, Doni L, Fulignati C, ct al. Raltitrexed plus oxaliplatin as first-line chemotherapy in metastatic colorectal carcinoma: a multicentric phase Ⅱ trial [J]. Anticancer Drags, 2002, 13 (7) :719 -724.